Search
for
Sort by
Research 121–150 of 1000+
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- Combination Therapy With CGF and Microneedling‐Assisted Compound Betamethasone for Resistant Alopecia Areata: APilot Study
- 51440 Characterizing the types and impact of dietary and nutritional modifications in the management of alopecia areata
- ALOPECIA AREATA PROFILING SHOWS LNCRNAS REGULATE THE SUPPRESSED EXPRESSION OF KERATIN.
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
- Molybdenum Nanoparticles as a Potential Topical Medication for Alopecia Treatment through Antioxidant Pathways that Differ from Minoxidil
- Gut Microbiota and Its Association with Alopecia Areata: Insights from a Two-Sample Mendelian Randomization Study
- The potential of regulatory T cell-based therapies for alopecia areata
- Diffuse neurofibroma of the scalp with alopecia areata as the initial presentation: a case report
- MODERN TREATMENT APPROACHES FOR ALOPECIA: CURRENT ADVANCES AND FUTURE PERSPECTIVES
- MODERN TREATMENT APPROACHES FOR ALOPECIA: CURRENT ADVANCES AND FUTURE PERSPECTIVES
- Crisaborole as a Potential Treatment for Pediatric Alopecia Areata: A Case Report and Literature Review
- Beyond Hair Regrowth: Interpreting the Psychosocial Impact of Ritlecitinib in Alopecia Areata
- Association of Janus kinase inhibitors with reduced depression in alopecia areata
- Table 1_Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study.docx
- Supplemental Material: Tolerability and Efficacy of Unorthodox Dosing Regimens of Tofacitinib and Baricitinib in Pediatric Patients with Moderate to Severe Alopecia Areata
- Supplemental Material: Tolerability and Efficacy of Unorthodox Dosing Regimens of Tofacitinib and Baricitinib in Pediatric Patients with Moderate to Severe Alopecia Areata
- Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Supplementary file 1_Periplaneta americana extract (L.) promotes hair regrowth in Alopecia areata mice by reducing inflammation and modulating skin microbiota.docx
- Intermittent Low-dose Ritlecitinib in Refractory Paediatric Alopecia Areata: A Case Report with Therapeutic Implications
- Supplementary file 1_Research progress in the treatment of non-scarring alopecia: mechanism and treatment.docx
- Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis
- CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1.
- Ultraviolet‐induced fluorescence dermoscopy in detecting follicular openings in alopecia areata
- Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study